Live feed
Filing
SC 13D/A
SC 13D/A0001214659-22-008768·LA JOLLA PHARMACEUTICAL CO
Schedule 13D ownership disclosure
LA JOLLA PHARMACEUTICAL CO
Security class unavailable · CUSIP: 503459604
Event date: 2022-07-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,607,934
- Percent of class
- 38.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-22-008768
- Form type
- SC 13D/A
- Filer
- LA JOLLA PHARMACEUTICAL CO
- CIK
- CIK 920465
- Filed
- Jul 12, 2022
- Reporting period
- Jul 10, 2022
- Description
- Schedule 13D beneficial ownership